It's been a light couple of weeks due to the partial government shutdown. Here are the latest recalls.
An efficient summary of all things FDA/GMP related for December 2018. Warning letters, refusals of inspections, new guidance, etc. See the rundown.
Mislabeling, lack of sterility, sub- and superpotent drugs. Here are the latest recalls.
This week, one warning letter was issued by CDER to a finished pharmaceutical manufacturer, and another was issued to a Genetech site that manufactures human cells/tissue-based products.
Last week there were a handful of recalls due to the presence of NDEA. Here are the latest.
FDA posted four warning letters this week including one to an API manufacturer, one to a compounding pharmacy and one to a drug product manufacturer.
From lack of sterility to discoloration, here are the latest recalls.
We compiled last week's warning letters for you. Take a look.
From high concentrations of ibuprofen for infants to a metal shard found in a tablet, here are the latest recalls.